Health Condition 1: I504- Combined systolic (congestive) anddiastolic (congestive) heart failure
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Cardiological Society of India
Eligibility
Inclusion criteria
Inclusion criteria: In this multicentric, retrospective, cross-sectional registry, we plan to retrospectively include consecutive patients presenting with acute HF at various participating hospitals across the Indian states/ union territories during a 6-months period in 2020 (1st of July to 31st December 2020). All cases of acute HF admitted during the corresponding period in the year 2019 will serve as historical controls.The parameters to be studied include type of HF, new-onset or worsening of pre-existing heart failure, clinical characteristics on index admission, risk factors, etiology for heart failure, history previous myocardial infarction, history of previous hospital admissions, treatment received during hospital admission, diagnostic coronary angiography, percutaneous coronary interventions, and coronary artery bypass graft surgery rates.
Exclusion criteria
Exclusion criteria: Patients with a first acute myocardial infarction in the 2 weeks preceding clinical presentation will be excluded. Patients with alternative diagnoses clearly causative of symptoms will also be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To study the change in the number of acute HF admissions in various hospitals in India during the period from 1st of July to 31st December 2020 (COVID-19 era) compared to corresponding period in 2019. 2.To study in-hospital mortality rates of ADHF admitted to the various hospitals during the COVID-19 era compared to corresponding period in 2019. 3.To study care of patients with LVAD and Heart transplant during COVID-19 times 4.To study the benefits of prophylaxis with HCQ/others Timepoint: The period from 1st of July to 31st December 2020 (COVID-19 era) compared to corresponding period in 2019 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To find out type of HF (HFpEF vs HFrEF), and rates of guideline directed medical therapy (GDMT), coronary angiography and revascularization in HF patients. 2.To evaluate the differences in the number of various advanced HF procedures performed in 2020 Vs. 2019 including ICD, CRT, mechanical assist devices and heart transplantation by a survey among the hospitals. 3.To study the changes in the prescription pattern of ACE inhibitor/ARB/ARNI.Timepoint: The period from 1st of July to 31st December 2020 (COVID-19 era) compared to corresponding period in 2019 | — |
Countries
India
Contacts
Public ContactDr Jayagopal P B
Director and Senior Interventional Cardiologist
Outcome results
None listed